Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term: consultation
PHARMAC web pages that matched your search: (hide)
Application Tracker – “consultation letters, and notifications that have been released relating to that application. You can search”
PHARMAC documents that matched your search:
Proposal to list sugammadex (Bridion) for reversal of neuromuscular blockade; Closing Date: Friday 15 February 2013; Contact: Geraldine MacGibbon
(2 pages, 116 KB)
2013/01/30
“consultation, PHARMAC is aware of other uses for sugammadex. We would be willing to consider”
30 January 2013 Proposal to list sugammadex (Bridion) for reversal of neuromuscular blockade PHARMAC is seeking feedback on a proposal to list sugammadex (Bridion) in Section H of the Pharmaceutical Schedule (the national Preferred Medicines List (PML)), subject to the…
Proposal to fund unapproved pharmaceutical treatments for various conditions; Closing Date: 5pm, Friday 1 February 2013; Contact: Geraldine MacGibbon
(10 pages, 188 KB)
2013/01/14
“consulted on including these medicines in the PML; the consultation document can be found at: www.pharmac.govt.nz”
14 January 2013 Proposal to fund unapproved pharmaceutical treatments for various conditions PHARMAC and Link Pharmaceuticals Limited have entered into a provisional agreement for the funding and supply of 11 pharmaceuticals that do not have Medsafe consent (i.e. are not…
Section H - effective 1 March 2013
(85 pages, 622 KB)
2013/02/26
“consultation when it intends to take any such “other criteria” into account. 2 The Operating”
Pharmaceutical Management Agency Section H for Hospital Pharmaceuticals Effective 1 March 2013 New Zealand Pharmaceutical Schedule Hospital Pharmaceuticals March 2013 Editors Sarah Le Leu & Donna Jennings email: schedule@pharmac.govt.nz Telephone +64 4 460 4990 Facsimile +64 4 460 4995 Level…
2013-02 Clinicians Newsletter
(3 pages, 150 KB)
2013/02/11
“from 1 February 2013, for the full reference; please consult your Update to the Pharmaceutical Schedule. ”
Pharmaceutical Management Agency Clinicians’ “Make life easier, always think generically” Newsletter February 2013 Extension of pharmacist claiming of CareSens Meters The Pharmaceutical Schedule rules were amended from 1 September 2012 to 1 march 2013 to allow pharmacists to provide and…
Proposal to fund sildenafil for the treatment of Raynaud's phenomenon; Closing Date: Closed; Contact: Stephen Woodruffe
(2 pages, 113 KB)
2012/12/10
“10 December 2012 Proposal to fund sildenafil for the treatment of Raynaud’s phenomenon PHARMAC”
10 December 2012 Proposal to fund sildenafil for the treatment of Raynaud’s phenomenon PHARMAC is seeking feedback on a proposal to: Fund sildenafil for patients with Raynaud’s phenomenon who meet the Special Authority eligibility criteria. The proposal does not…
Annual Review 2012
(36 pages, 2535 KB)
2013/01/31
“consulted on a proposal to fund three blood glucose testing meters and their testing strips”
Pharmaceutical Management Agency Annual Review 2012 2011/12 Highlights Pharmaceutical funding • Community and cancer pharmaceutical funding managed on budget - $777.4 million • 24 new investments in medicine – including 14 new medicines and 10 widened access • New investments…
Proposal to fund capsaicin cream, atenolol oral liquid and bosentan and to amend the listing of erythromycin lactobionate IV; Closing Date: Closed; Contact: Christine Chapman
(3 pages, 136 KB)
2012/12/07
“7 December 2012 Proposal to fund capsaicin cream, atenolol oral liquid and bosentan and to”
7 December 2012 Proposal to fund capsaicin cream, atenolol oral liquid and bosentan and to amend the listing of erythromycin lactobionate IV. PHARMAC has entered into a provisional agreement with AFT Pharmaceuticals relating to the listing of various products in…
Proposal for sole supply of tacrolimus; Closing Date: Closed; Contact: Jackie Evans
(5 pages, 152 KB)
2012/12/05
“consult with transplant clinicians which would give sufficient notice of the timelines for any brand”
5 December 2012 Proposal for sole supply of tacrolimus PHARMAC is seeking feedback on a proposal to: List Sandoz’s brand of tacrolimus 0.5 mg, 1 mg and 5 mg capsules (Tacrolimus Sandoz) in Section B, and Part II of…
PHARMAC publishes its 2012 Annual Review
(2 pages, 77 KB)
2013/01/31
“consult on and finalise the requirements for using hospital medicines, prior to a national list”
31 January 2013 Media release PHARMAC gearing up for broader impact in health procurement PHARMAC is on track to meet targets set in relation to its expanded role with medical devices and hospital medicines. The Government pharmaceutical funder is now…
Decisions relating to hospital medicines funding; Contact: Notifications; Posted: 2013-01-29
(4 pages, 121 KB)
2013/01/29
“consultation letter dated 3 August 2012. These decisions establish the first two (of sixteen) ‘therapeutic”
29 January 2013 Decisions relating to hospital medicines funding PHARMAC is pleased to announce that the first set of decisions have been made to establish a nationally-consistent list of medicines to be funded within DHB hospitals. This proposal was the…
Page updated on 22 May 2013
